XM does not provide services to residents of the United States of America.
S
S

Snap-On


News

Snap-On Raises Dividend 15.1%

BRIEF-Snap-On Raises Dividend 15.1% Nov 8 (Reuters) - Snap-On Inc SNA.N : SNAP-ON RAISES DIVIDEND 15.1% SNAP-ON INC - INCREASES QUARTERLY DIVIDEND TO $2.14 PER SHARE Source text: ID:nBw51J3p7a Further company coverage: SNA.N ( Reuters.Briefs@thomsonreuters.com )
S

U.S. Galapagos, Marsh & Mclennan, Travelers

U.S. RESEARCH ROUNDUP-Galapagos, Marsh & Mclennan, Travelers Oct 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Galapagos, Marsh & Mclennan and Travelers, on Tuesday. HIGHLIGHTS * Contineum Therapeutics Inc CTNM.O : Baird initiates coverage with outperform rating * Galapagos NV GLPG.O : JP Morgan cuts target price to $32 from $37 * Marsh & Mclennan MMC.N : KBW raises target price to $212 from $209 * Travelers TRV.
A
C
E
E
G
M
T
W
Z
A
F
T
L
P
U
W
P
S

U.S. Elevance Health, Microsoft, UnitedHealth

U.S. RESEARCH ROUNDUP-Elevance Health, Microsoft, UnitedHealth Oct 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Elevance Health, Microsoft, and UnitedHealth, on Friday. HIGHLIGHTS * Air Products APD.N : JP Morgan raises target price to $350 from $340 * Elevance Health ELV.N : RBC cuts target price to $478 from $585 * Microsoft MSFT.O : Piper Sandler cuts target price to $470 from $485 * Texas Capital Bancshares
A
B
D
H
M
N
A
E
E
E
M
M
S

U.S. STOCKS Avery Dennison, Snap-On, Avadel Pharma

BUZZ-U.S. STOCKS ON THE MOVE-Avery Dennison, Snap-On, Avadel Pharma Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street gained on Thursday, with the S&P 500 and the Dow touching intraday record highs, driven by TSMC's upbeat forecast and a bigger-than-expected rise in monthly retail sales indicating a strong U.S.
A
B
C
E
I
N
N
R
S
S
S
U
U
U
U
T
U
W
W
A
E
M
S

S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT S&P 500 .SPX Top Performers Percent Change Snap-On Inc SNA.N +9.1% Travelers Companies Inc TRV.N +7.6% Blackstone Inc BX.N +6.4% Broadcom Inc AVGO.OQ +4.9% Steel Dynamics Inc STLD.OQ +4.7% Bottom Performers Percent Change Elevance Health Inc ELV.N -12.1% Molina Healthcare Inc M
B
C
S
W
U
S

Snap-On rises after Q3 profit beat

BUZZ-Snap-On rises after Q3 profit beat ** Shares of tool maker Snap-On SNA.N rise 6.7% to $317.98 ** Company's Q3 adjusted earnings per share of $4.70 beats analysts' estimate of $4.59, data compiled by LSEG shows ** SNA's profit growth was largely aided by lower costs ** But Q3 revenue of $1.15 bln misses estimate of $1.16 bln, as sales fall acro
S

Snap-on Announces Third Quarter 2024 Results

BRIEF-Snap-on Announces Third Quarter 2024 Results Oct 17 (Reuters) - Snap-On Inc SNA.N : SNAP-ON ANNOUNCES THIRD QUARTER 2024 RESULTS SNAP-ON INC- QTRLY DILUTED EPS OF $4.70 Source text for Eikon: ID:nBw8FqLhKa Further company coverage: SNA.N
S

Snap-On misses quarterly sales estimates on lower tool demand

Snap-On misses quarterly sales estimates on lower tool demand Oct 17 (Reuters) - Snap-On SNA.N posted a lower-than-expected third-quarter sales on Thursday, as inflationary pressures weighed on demand in the tools segment. Higher borrowing costs and a rise in prices of tools - one of the company's biggest revenue drivers - have led customers to limit purchases.
S

Snap-On Q3 Sales USD 1,147 Million Vs. IBES Estimate USD 1,157 Million

BRIEF-Snap-On Q3 Sales USD 1,147 Million Vs. IBES Estimate USD 1,157 Million Oct 17 (Reuters) - Snap-On Q3 adjusted operating earnings USD 252.4 million vs. IBES estimate USD 322.8 million. Q3 gross profit USD 587.8 million Q3 pretax profit USD 332.2 million vs. IBES estimate USD 323.6 million Q3 net income USD 257.5 million vs. IBES estimate USD 2
S

TSMC steadies chip ship, ECB set to ease

MORNING BID AMERICAS-TSMC steadies chip ship, ECB set to ease A look at the day ahead in U.S. and global markets from Mike Dolan Tech-heavy stock markets are set to breathe a sigh of relief on Thursday as the world's largest chipmaker beat the street and eased gnawing doubts about semiconductor demand worldwide and jitters about the wider artificial intelligence theme.
A
E
E
H
L
M
N
N
U
A
J
U
U
U
U
M
S

U.S. earnings week ahead

DIARY-U.S. earnings week ahead Oct 11 (Reuters) - Diary of U.S. (.SPX) corporate earnings for the week ahead. ** Please Note - All times given are in U.S. EDT unless otherwise stated ** U.S. EARNINGS Start Date Start Time RIC Company Name Event Name 15-Oct-2024 AMC JBHT.O J B Hunt Transport Services Inc Q3 2024 J B Hunt Transport Services Inc Earnings Release 15-Oct-2024 AMC UAL.O United Airlines Holdings Inc Q3 2024 United Airlines Holdings Inc Earnings Release 15-Oct-2024 AMC OMC Omnicom Group
A
C
C
G
H
N
S
W
F
J
U
C
E
M
P
S



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.